Our company was founded in response to the groundbreaking advancements in the fields of life sciences and information technology that have emerged since the 2000s. These innovations have transformed the landscape of healthcare, allowing for the simultaneous analysis of genes, cells, and proteins, and paving the way for a new era in diagnosis and treatment.

However, with these advancements have come new challenges, particularly the increasing complexity of diseases and the need for more precise and effective treatments.

Traditionally, disease diagnosis relied heavily on microscopy, but today, genetic analysis has revolutionized how we understand and classify illnesses. For instance, the case of Angelina Jolie, who underwent preventive surgery after discovering a genetic predisposition to breast cancer, highlights the potential of modern diagnostics.

Yet, this increased precision in diagnosis has also led to a paradox : the more specific the diagnosis, the fewer treatment options are available for some patients. This has created a critical need for new therapeutic solutions.

Recognizing this gap, we established our company to develop innovative therapies that address these unmet medical needs. Our mission is to create new treatments based on cutting-edge approaches such as gene therapy, cell therapy, and targeted protein therapeutics. The current state of drug discovery is limited in its ability to target only about 20% of the body’s potential druggable targets, leaving the remaining 80% classified as “undruggable.”

Despite these challenges, we believe that with persistent scientific innovation, it is possible to develop effective treatments even for these previously inaccessible targets.

Moreover, the complexity of diseases like cancer, where single-target therapies often fall short due to the emergence of drug resistance, has driven us to focus on the development of multi-functional therapeutics.

These new treatments, such as bispecific and trispecific antibodies, are designed to target multiple disease mechanisms simultaneously, offering hope for more effective and durable responses.